AboundBio

In first M&A strike, Paul Stoffels lays out 5-year plan to turn Galapagos around
Fierce Biotech
Thu, 06/23/22 - 10:54 am
Galapagos
Pharma CEOs
Paul Stoffels
M&A
CAR-T
AboundBio
CellPoint
Galapagos to enter cell therapy space with acquisition of CellPoint and AboundBio
Seeking Alpha
Tue, 06/21/22 - 11:50 pm
Galapagos
cell therapy
CellPoint
AboundBio
CAR-T